M. Neubauer

Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology

Shadia I. Jalal, Heather Riggs, A. Melnyk et al. · Annals of Oncology · 2011 · 79 citations · Full text

Radiation Medicine, Hoosier Oncology Group, Medicine +11

Panitumumab antitumor activity in patients (pts) with metastatic colorectal cancer (mCRC) expressing ≥ 10% epidermal growth factor receptor (EGFr)

Jordan Berlin, M. Neubauer, Paul Swanson et al. · Journal of Clinical Oncology · 2006 · 65 citations

Gastrointestinal Oncology, Medicine, Human Monoclonal Antibody +13

Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01–24/USO-023

Nasser H. Hanna, M. Neubauer, Rafat Ansari et al. · Journal of Clinical Oncology · 2007 · 60 citations

Radiation Medicine, Oncology, Radiation Therapy +15

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang et al. · Annals of Oncology · 2013 · 55 citations

Antifibrotic Therapy, Fortis-m Trial, Medicine +9

Risk profile analysis and complications after surgery for autoimmune thyroid disease

Oliver Thomusch, Carsten Sekulla, Franck Billmann et al. · British journal of surgery · 2018 · 34 citations